We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

NIH Names Walter J. Koroshetz, M.D. Director of the NINDS

News   Jun 13, 2015

 
NIH Names Walter J. Koroshetz, M.D. Director of the NINDS
 
 
Advertisement
 

RELATED ARTICLES

Large Clinical Trial To Test Polyclonal Antibody Therapeutic for COVID-19

News

A trial evaluating a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

READ MORE

Encouraging Early Results From Clinical Trial of Gene Therapy for Childhood Blindness

News

According to a clinical trial, a new gene therapy for one of the most common forms of congenital blindness was safe and improved patients’ vision.

READ MORE

Large Trial To Investigate Repurposed Drugs To Treat Mild-to-Moderate COVID-19

News

The large, randomized, placebo‑controlled Phase 3 clinical trial will explore up to seven drugs approved by US Food and Drug Administration (FDA) for other conditions – an approach called drug repurposing – and test their safety and effectiveness in treating mild-to-moderate COVID-19.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE